History of Therapeutic Use

40 years ago, a therapeutic challenge initiated the development of the ultrafiltrates of fetal and juvenile organs.

Figure 1: Improvements of the keloid scar

A young, 8 year old girl, due to an explosion of a petroleum stove, sustained a deep burn of the upper right side of the body. A disfiguring hypertrophic scar due to overgrown skin developed on the neck and face (Figure 1.). An effort was made to eliminate the ½ inch thick deformed hypertrophic scar by applications of the specially prepared cell extract from fetal skin was successful.

A young, 8 year old girl, due to an explosion of a petroleum stove, sustained a deep burn of the upper right side of the body. A disfiguring hypertrophic scar due to overgrown skin developed on the neck and face (Figure 1.). An effort was made to eliminate the ½ inch thick deformed hypertrophic scar by applications of the specially prepared cell extract from fetal skin was successful.

Figure 1: Improvements of the keloid scar

Figure 2: Improvements from a third degree burn

Upon such success, many other patients with severe deep burns (Figure 2) from Germany and Switzerland were put up with such therapeutic aids, if untreatable by other means. Later, various ultrafiltrate therapeutic aids were tested and further propositions were established.

Upon such success, many other patients with severe deep burns (Figure 2) from Germany and Switzerland were put up with such therapeutic aids, if untreatable by other means. Later, various ultrafiltrate therapeutic aids were tested and further propositions were established.

Figure 2: Improvements from a third degree burn

Upon the success of the absorption of the fetal ultrafiltrate through the skin, their epithelialising effect was established by impressive histological study of F.Leyh in 1981-1983. If the skin is permissible for the absorption of the ultrafiltrate, then it would be anticipating for the skin mucosa to transport the ultrafiltrate to specific or all organs and tissues into the organism. After the positive therapeutic effect was observed, oral administration of ultrafiltrate was born. The successful responses initiated the design of combinations of ultrafiltrates for various organs and tissues (liver, pancreas, placenta, stomach, intestinal, mucosa (LPPSIM) to assist in regeneration of deteriorating intestinal mucosa and in treatment of metabolic diseases and later, the ultrafiltrate of central nervous system (CNS) was created.

The observed responses led to the design of combinations of EUF of various organs and tissues used in sequence for biological regeneration of disordered organ systems.

Legal Disclaimer: All information contained here is intended for informational and educational purposes. The information is not intended nor suited to be a substitute for professional medical treatment or for professional medical advice.